Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech, Indications -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (8)	7/8/1999 11:34:00 PM
From: mike head	Respond to of 22

David. Great idea for a new thread--- if it can foment discussion! There are numerous sites which simply list different indications, but I can't recall seeing one where critical opinion was involved! Here's hoping... For sheer reference material, here's a good site. Just plug in the indication, and Voila! (I had it set on Psoriasis...) biospace.com pax et bonum, mch

To: LLCF who wrote (8)	7/9/1999 2:49:00 AM
From: sim1	Respond to of 22

Alzheimer's... From EBEWE Pharmaceuticals Ltd (An Austrian Co.) ebewe.co.at Have no idea if there is any value here. "...We at EBEWE recognised the importance of pivotal research at an early stage and started future-oriented studies. Our proud result: Cerebrolysin®. Cerebrolysin® is the new innovative standard for the treatment of Alzheimer's disease and stroke - because of Cerebrolysin®'s unique neurotrophic mechanism of action. After Cerebrolysin® treatment, stroke patients experience improved neurorehabilitation and the amount of care needed by Alzheimer's disease sufferers decreases significantly." (snip)